Testing effectiveness (Phase 2)Ended earlyNCT01966887
What this trial is testing
AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure
Who this might be right for
Heart Failure CongestiveIschemic CardiomyopathyNon-ischemic Cardiomyopathy
Assistance Publique - Hôpitaux de Paris 10